Abstract
Intravenous immunoglobulin (IVIG) is a fractioned blood product consisting of IgG antibodies which was first used in antibody deficiency disorders. It is increasingly being used for several inflammatory and autoimmune conditions. IVIG can also be used in a wide range of dermatological diseases which are difficult to treat including autoimmune bullous skin diseases and toxic epidermal necrolysis. The use of IVIG in dermatological disorders is discussed in this article.
Keywords: Dermatology, intravenous immunoglobulin, mechanism of action, side effects, skin.
Inflammation & Allergy - Drug Targets (Discontinued)
Title:Intravenous Immunoglobulın Therapy in Dermatology: An Update
Volume: 12 Issue: 2
Author(s): Seray Kulcu Cakmak, At l Cakmak, Muzeyyen Gonul, Arzu K l c and Ulker Gul
Affiliation:
Keywords: Dermatology, intravenous immunoglobulin, mechanism of action, side effects, skin.
Abstract: Intravenous immunoglobulin (IVIG) is a fractioned blood product consisting of IgG antibodies which was first used in antibody deficiency disorders. It is increasingly being used for several inflammatory and autoimmune conditions. IVIG can also be used in a wide range of dermatological diseases which are difficult to treat including autoimmune bullous skin diseases and toxic epidermal necrolysis. The use of IVIG in dermatological disorders is discussed in this article.
Export Options
About this article
Cite this article as:
Cakmak Kulcu Seray, Cakmak At l, Gonul Muzeyyen, K l c Arzu and Gul Ulker, Intravenous Immunoglobulın Therapy in Dermatology: An Update, Inflammation & Allergy - Drug Targets (Discontinued) 2013; 12 (2) . https://dx.doi.org/10.2174/1871528111312020007
DOI https://dx.doi.org/10.2174/1871528111312020007 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Immunogenicity in Protein and Peptide Based-Therapeutics: An Overview
Current Protein & Peptide Science Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy
Current Diabetes Reviews Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued) Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications
Current Pharmaceutical Design Platelet Biomarkers in Tumor Growth
Current Proteomics Synthesis, Toxicity Profile and Pharmacological Evaluation of Some New N,N-Diphenyl Amine Derivatives with Special Reference to Analgesic and Anti-inflammatory Activity
Letters in Organic Chemistry Genetically Engineered Stem Cells for Therapeutic Gene Delivery
Current Gene Therapy Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches
CNS & Neurological Disorders - Drug Targets Mesenchymal Stem Cells Derived from Wharton's Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications
Current Stem Cell Research & Therapy Bioinformatics-Based Characterization of Proteins Related to SARS-CoV- 2 Using the Polarity Index Method<sup>®</sup> (PIM<sup>®</sup>) and Intrinsic Disorder Predisposition
Current Proteomics Assessing the Gender Differences of Adverse Effects in HIV Infection Treatment Based on FDA AERS Database.
Current Bioinformatics Mesenchymal Stem Cell Research in Veterinary Medicine
Current Stem Cell Research & Therapy The Human Pseudoautosomal Region (PAR): Origin, Function and Future
Current Genomics The Current View on the Helicase Activity of RNA Helicase A and Its Role in Gene Expression
Current Protein & Peptide Science A Review of Polymeric Colloidal Nanogels in Transdermal Drug Delivery
Current Pharmaceutical Design Potential Role of TRP Channels in Cough Hypersensitivity?
Current Respiratory Medicine Reviews Cytokine Network: New Targeted Therapy for Pancreatic Cancer
Current Pharmaceutical Design Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) High-Density Lipoprotein-Raising Strategies: Update 2010
Current Pharmaceutical Design